In patients with liver cirrhosis and those in whom liver transplant is planned, after the decompensated form of the disease is stabilized, cardiac troponins (cTnI and cTnT) and NT-proBNP concentrations can identify the patients who have developed cirrhotic cardiomyopathy or who are at an increased risk of the disease. Here, TNNT2 is linked to cirrhosis of liver.